Literature DB >> 16143682

Implications of the new definition of myocardial infarction.

C-K Wong1, H D White.   

Abstract

The new definition of acute myocardial infarction is based primarily on raised troponin levels because of the sensitivity and specificity of these markers and their correlation with the pathophysiology of acute coronary syndromes with plaque fissuring or rupture and embolisation of platelets causing myocyte necrosis. Raised troponin levels are associated with increased risks of death and recurrent myocardial infarction. Greater treatment benefit with low molecular weight heparin, IIb/IIIa antagonists and revascularisation is seen when troponin levels are raised. There are many implications for patients and society of the new definition including changes in insurability and ability to continue certain occupations. Many more patients, who would previously been diagnosed as having unstable angina, will now be diagnosed as having had an acute myocardial infarction. In addition case fatality rates will fall and comparison with previous epidemiological studies using the old definition will be problematic. However, the new definition may result in greater use of evidence based therapies with improved patient outcomes and decreased community death rates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16143682      PMCID: PMC1743361          DOI: 10.1136/pgmj.2005.035071

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  19 in total

1.  Comment on the ESC/ACC redefinition of myocardial infarction by a consensus dissenter.

Authors:  H Tunstall-Pedoe
Journal:  Eur Heart J       Date:  2001-04       Impact factor: 29.983

2.  Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy.

Authors:  D A Morrow; E M Antman; M Tanasijevic; N Rifai; J A de Lemos; C H McCabe; C P Cannon; E Braunwald
Journal:  J Am Coll Cardiol       Date:  2000-11-15       Impact factor: 24.094

3.  Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes.

Authors:  F Ottani; M Galvani; F A Nicolini; D Ferrini; A Pozzati; G Di Pasquale; A S Jaffe
Journal:  Am Heart J       Date:  2000-12       Impact factor: 4.749

4.  Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease.

Authors:  Fred S Apple; MaryAnn M Murakami; Lesly A Pearce; Charles A Herzog
Journal:  Circulation       Date:  2002-12-03       Impact factor: 29.690

Review 5.  Clinical implications of the new definition of myocardial infarction.

Authors:  John K French; Harvey D White
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

6.  Cardiac troponin elevations in chronic renal failure: prevalence and clinical significance.

Authors:  P Musso; I Cox; E Vidano; D Zambon; M Panteghini
Journal:  Clin Biochem       Date:  1999-03       Impact factor: 3.281

7.  Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management.

Authors:  C Heeschen; C W Hamm; B Goldmann; A Deu; L Langenbrink; H D White
Journal:  Lancet       Date:  1999-11-20       Impact factor: 79.321

8.  Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.

Authors:  E M Antman; M J Tanasijevic; B Thompson; M Schactman; C H McCabe; C P Cannon; G A Fischer; A Y Fung; C Thompson; D Wybenga; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-31       Impact factor: 91.245

9.  Impact of the troponin standard on the prevalence of acute myocardial infarction.

Authors:  Michael C Kontos; Lucie M Fritz; F Philip Anderson; James L Tatum; Joseph P Ornato; Robert L Jesse
Journal:  Am Heart J       Date:  2003-09       Impact factor: 4.749

10.  Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction.

Authors:  Ronnier J Aviles; Arman T Askari; Bertil Lindahl; Lars Wallentin; Gang Jia; E Magnus Ohman; Kenneth W Mahaffey; L Kristin Newby; Robert M Califf; Maarten L Simoons; Eric J Topol; Peter Berger; Michael S Lauer
Journal:  N Engl J Med       Date:  2002-06-27       Impact factor: 91.245

View more
  1 in total

1.  Cardiorenal syndromes and sepsis.

Authors:  C Chelazzi; G Villa; A R De Gaudio
Journal:  Int J Nephrol       Date:  2011-03-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.